Wow, right? Imagine you bought $10,000 of shares in Intuitive Surgical a decade ago. What would they be worth now? Well, the ...

The lawsuit from Surgical Instrument Service centered around Intuitive Surgical's programmed usage limits for its EndoWrist ...

Intuitive Surgical stock (NASDAQ: ISRG) saw an 8% rise on Wednesday, January 15, after the company reported upbeat Q4 preliminary sales. It expects sales of $2.4 billion in Q4, reflecting a solid ...

Intuitive Surgical, Inc. (ISRG) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Intuitive Surgical ISRG +1.44% Get Free Report has outperformed the market over the past 10 years by 15.36% on an annualized ...

Intuitive Surgical's preliminary Q4 results easily surpassed analysts' expectations. Revenue growth clocked in well above the company's historical averages. Installing more of its systems than ...

Intuitive Surgical expects to report fourth-quarter revenue of approximately $2.41 billion, versus analyst estimates of $2.2 billion. The company expects worldwide da Vinci procedures to grow ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Intuitive Surgical shares hit another record high Thursday as investor sentiment runs ...

Intuitive Surgical (NASDAQ: ISRG) should arguably be doing a whole lot better after coming off the release of some strong earnings numbers. Business is doing well, the growth rate is solid ...

Medical technology company Intuitive Surgical (NASDAQ:ISRG) announced better-than-expected revenue in Q4 CY2024, with sales up 25.2% year on year to $2.41 billion. Its non-GAAP profit of $2.21 per ...

Investors with a lot of money to spend have taken a bearish stance on Intuitive Surgical (NASDAQ:ISRG). And retail traders should know. We noticed this today when the trades showed up on publicly ...

Intuitive Surgical's share price surged after the company reported 25% YoY revenue growth in the fourth quarter. Despite macro headwinds, robust procedure volumes, international expansion and new ...